Eris Lifesciences Ltd

NSE: ERIS · BSE: 540596 · Pharmaceuticals & Biotechnology · 41 announcements

Share price: ₹1,145.80
Market cap: ₹15,897 Cr
Revenue (annual): ₹3,129 Cr
Net profit (annual): ₹619.5 Cr
P/E (TTM): 24.7×Sector 47.3×
Promoter holding: 54.14%+0.22% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Employee Stock Options 6 Debt & Borrowing 6 Annual General Meeting 5 Financial Results 4 Management Change 3 Other Announcement 2 Credit Rating 2 Price Movement Clarification 1 Legal & Regulatory 1 Dividend 1 Board Meeting Date 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

18 Jul 2026 18:03 IST BSE

Other Announcement

Eris Lifesciences Other Announcement

Eris Lifesciences filed its quarterly shareholding pattern for the period ending June 30, 2026. No major promoter changes or material financial events reported.

Read the filing ↗

27 May 2026 18:14 IST BSE

Other Announcement

Eris Lifesciences Other Announcement

Eris Lifesciences filed its FY2026 Secretarial Compliance Report, noting a Rs. 0.13 Crore fine for delayed director appointment. The company has since achieved full compliance.

Value: ₹0.13 Cr

Read the filing ↗